ANVS
Price
$2.26
Change
-$0.00 (-0.00%)
Updated
Oct 7 closing price
Capitalization
44.04M
28 days until earnings call
RXRX
Price
$5.23
Change
-$0.30 (-5.42%)
Updated
Oct 7 closing price
Capitalization
2.28B
28 days until earnings call
Interact to see
Advertisement

ANVS vs RXRX

Header iconANVS vs RXRX Comparison
Open Charts ANVS vs RXRXBanner chart's image
Annovis Bio
Price$2.26
Change-$0.00 (-0.00%)
Volume$182.24K
Capitalization44.04M
Recursion Pharmaceuticals
Price$5.23
Change-$0.30 (-5.42%)
Volume$34.12M
Capitalization2.28B
ANVS vs RXRX Comparison Chart in %
ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANVS vs. RXRX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANVS is a StrongBuy and RXRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 08, 2025
Stock price -- (ANVS: $2.26 vs. RXRX: $5.23)
Brand notoriety: ANVS and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANVS: 83% vs. RXRX: 142%
Market capitalization -- ANVS: $44.04M vs. RXRX: $2.28B
ANVS [@Biotechnology] is valued at $44.04M. RXRX’s [@Biotechnology] market capitalization is $2.28B. The market cap for tickers in the [@Biotechnology] industry ranges from $105.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANVS’s FA Score shows that 1 FA rating(s) are green whileRXRX’s FA Score has 1 green FA rating(s).

  • ANVS’s FA Score: 1 green, 4 red.
  • RXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, RXRX is a better buy in the long-term than ANVS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANVS’s TA Score shows that 5 TA indicator(s) are bullish while RXRX’s TA Score has 5 bullish TA indicator(s).

  • ANVS’s TA Score: 5 bullish, 3 bearish.
  • RXRX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ANVS is a better buy in the short-term than RXRX.

Price Growth

ANVS (@Biotechnology) experienced а +9.18% price change this week, while RXRX (@Biotechnology) price change was +7.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.19%. For the same industry, the average monthly price growth was +15.97%, and the average quarterly price growth was +89.17%.

Reported Earning Dates

ANVS is expected to report earnings on Nov 05, 2025.

RXRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+8.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.28B) has a higher market cap than ANVS($44M). RXRX YTD gains are higher at: -22.633 vs. ANVS (-55.070). ANVS has higher annual earnings (EBITDA): -23.68M vs. RXRX (-583.64M). RXRX has more cash in the bank: 525M vs. ANVS (17.1M). RXRX has higher revenues than ANVS: RXRX (64.5M) vs ANVS (0).
ANVSRXRXANVS / RXRX
Capitalization44M2.28B2%
EBITDA-23.68M-583.64M4%
Gain YTD-55.070-22.633243%
P/E RatioN/AN/A-
Revenue064.5M-
Total Cash17.1M525M3%
Total DebtN/A88.1M-
TECHNICAL ANALYSIS
Technical Analysis
ANVSRXRX
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 7 days ago
84%
Declines
ODDS (%)
Bearish Trend 13 days ago
89%
Bearish Trend 24 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RVSN0.810.29
+57.27%
Rail Vision Ltd
SCPH5.67N/A
N/A
scPharmaceuticals
FLNG25.30-0.06
-0.24%
FLEX LNG Ltd
VRNS59.98-0.75
-1.23%
Varonis Systems
CAT486.71-8.67
-1.75%
Caterpillar

ANVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANVS has been loosely correlated with ADXN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ANVS jumps, then ADXN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANVS
1D Price
Change %
ANVS100%
N/A
ADXN - ANVS
43%
Loosely correlated
-3.77%
RXRX - ANVS
37%
Loosely correlated
-5.42%
AMLX - ANVS
37%
Loosely correlated
+6.30%
ATXS - ANVS
37%
Loosely correlated
-2.86%
MDGL - ANVS
36%
Loosely correlated
-1.36%
More